Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

2016 ◽  
Vol 31 (10) ◽  
pp. 1910-1910 ◽  
Author(s):  
Robert A Adler ◽  
Ghada El-Hajj Fuleihan ◽  
Douglas C Bauer ◽  
Pauline M Camacho ◽  
Bart L Clarke ◽  
...  
2016 ◽  
Vol 31 (1) ◽  
pp. 16-35 ◽  
Author(s):  
Robert A Adler ◽  
Ghada El-Hajj Fuleihan ◽  
Douglas C Bauer ◽  
Pauline M Camacho ◽  
Bart L Clarke ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Tero Yli-Kyyny

Bisphosphonates are the most widely prescribed medicines for the treatment of osteoporosis and have generally been regarded as well-tolerated and safe drugs. Since 2005, there have been numerous case reports about atypical fractures of the femur linked to long-term treatment of osteoporosis with bisphosphonates. Some attempts to characterize pathophysiology and epidemiology of these fractures have been published as well. However, as the American Society for Bone and Mineral Research (ASBMR) concluded in their task force report, the subject warrants further studies.


2017 ◽  
Vol 32 (9) ◽  
pp. 1935-1944 ◽  
Author(s):  
Alexander J Rodriguez ◽  
Howard A Fink ◽  
Lynn Mirigian ◽  
Nuria Guañabens ◽  
Richard Eastell ◽  
...  

2019 ◽  
Vol 35 (1) ◽  
pp. 3-17 ◽  
Author(s):  
Regis J O'Keefe ◽  
Rocky S Tuan ◽  
Nancy E Lane ◽  
Hani A Awad ◽  
Frank Barry ◽  
...  

2020 ◽  
Vol 38 (3) ◽  
pp. 485-502 ◽  
Author(s):  
Regis J. O'Keefe ◽  
Rocky S. Tuan ◽  
Nancy E. Lane ◽  
Hani A. Awad ◽  
Frank Barry ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document